The study evaluate the effect of 10 neurofeedback sessions on the residual symptoms of depressive patients in partial remission.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
22
10 Neurofeedback sessions, psychiatric interview (MADRS, QIDS-C16), reverse-correlation task, QIDS-SR16, EQ-5D-5L, motivation assessment
CHU Besançon
Besançon, France
RECRUITINGEvaluate the effect of 10 neurofeedback sessions on residual symptoms in depressive patients in partial remission
Reduction in MADRS score to \< 8 (complete remission) after 10 neurofeedback sessions, in particular cumulative score less than or equal to 2 for hedonic and fatigue dimensions
Time frame: Week 10
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.